The Government of Manitoba — HIV/AIDS Research

IMRIC Location: 
IMRIC, the Hebrew University of Jerusalem
Partner Location(s): 
University of Manitoba/Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB
IMRIC Contact Person: 
Prof. Ofer Mandelboim, Faculty Member, Immunology and Cancer Research, IMRIC

Dr. Frank Plummer's team at the University of Manitoba and Dr. Ofer Mandelboim's team at IMRIC have completed their first year of collaborative research. Researchers from both Winnipeg and Jerusalem travelled to Kenya, and their work in the field showed that NK cells do play a role in building resistance to infectious diseases such as HIV.

Thanks to a commitment of $1.1 million for the first three years of research, allocations of new research funds from the two universities, a grant from the Winnipeg Foundation and a $100,000 a year commitment from the Government of Manitoba for three years, the IMRIC collaboration will continue in its pursuit to develop a vaccine to fight HIV.

Continuing the work already begun in their first year, this collaboration will focus, in year two, on micro-RNA and gene sequencing to determine the role played by genetics in developing natural resistance to infectious diseases. 

Collaborative Projects

HIV/AIDS Research

Dr. Frank Plummer's team at the University of Manitoba and Prof. Ofer Mandelboim's team at IMRIC have completed their first year of collaborative research. Researchers from both Winnipeg and Jerusalem travelled to Kenya, and their work in the field showed that NK cells do play a role in building resistance to infectious diseases such as HIV.